| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Primary completion pushed: 2027-03-03 -> 2029-01-10 |
| 2026-06-12 | NCT07421167 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… |
date change Completion pushed: 2027-03-31 -> 2030-09-18 |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
critical why stopped: null → "The registration of this research plan was incorrect. A new registration has been re-applied for." |
| 2026-06-05 | NCT07523009 CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA |
Enrollment reduced: 43 -> 0 participants |
| 2026-06-05 | NCT07532408 Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-06-05 | NCT07532408 Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA |
critical why stopped: null → "The registration of this research plan was incorrect. A new registration has been done." |
| 2026-06-05 | NCT07532408 Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA |
Enrollment reduced: 43 -> 0 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-28 | NCT07612319 Romiplostim for Oral TPO-RA Resistant ITP | Recruiting | |
| 2026-05-22 | NCT07600905 Avatrombopag for Severe Thrombocytopenia After Liver Transplantation: A Retrospective… | Completed | |
| 2026-05-14 | NCT07586813 Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Phase 2 | Recruiting |
| 2026-05-14 | NCT07586826 Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT04518475 | Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune… | Primary Immune Thrombocytopenia (ITP) | Recruiting |
| Phase 3 | |||
| NCT06759636 | A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared… | CTIT: Cancer Therapy Induced Thrombocytopenia | Recruiting |
| NCT07345000 | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe… | Treatment-naïve Severe Aplastic Anemia | Not Yet Recruiting |
| NCT03937154 | Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With… | Chemotherapy-induced Thrombocytopenia | Active, Not Recruiting |
| NCT05653219 | A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in… | Primary Immune Thrombocytopenia | Active, Not Recruiting |
| Phase 2 | |||
| NCT04304820 | Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive… | Severe Aplastic Anemia | Recruiting |
| NCT06345495 | High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients… | Splenomegaly | Recruiting |
| NCT07278661 | Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. | Chirurgical Intervention | Recruiting |
| NCT07400341 | Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA | MDS (Myelodysplastic Syndrome) | Recruiting |
| NCT07043894 | Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients | Solid Tumors | Recruiting |
| NCT07586813 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07586826 | Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia… | Persistent Isolated Chemotherapy-Induced Thrombocytopenia | Recruiting |
| NCT07421167 | A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice… | Primary Immune Thrombocytopenia (ITP) | Recruiting |
| NCT07400250 | Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With… | Primary Immune Thrombocytopenia (ITP) | Not Yet Recruiting |
| NCT05772546 | Avatrombopag vs. Placebo for CIT in GI Malignancies | Gastrointestinal Cancer | Active, Not Recruiting |
| NCT04797000 | Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet… | Myelodysplastic Syndromes | Active, Not Recruiting |
| NCT07558434 | CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA | Severe Aplastic Anemia (SAA) | Not Yet Recruiting |
| NCT07572084 | Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia | Aplastic Anemia | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07113743 | Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked… | Chronic Granulomatous Disease (CGD) | Enrolling by Invitation |
| Phase 1 | |||
| NCT07321626 | Romiplostim N01 for Platelet Recovery After Haploidentical HSCT | Acute Myeloid Leukemia | Recruiting |
| NCT06880081 | Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP) | Primary Immune Thrombocytopenia (ITP) | Recruiting |
| Early Phase 1 | |||
| NCT07048249 | Single Arm Romiplostim to Prevent CIT | Ewings Sarcoma | Recruiting |
| Not specified | |||
| NCT07612319 | Romiplostim for Oral TPO-RA Resistant ITP | Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Recruiting |